Global Equine Pharmaceuticals and Supplements Market Overview And Scope:
Global Equine Pharmaceuticals and Supplements Market Size was estimated at USD 1155.44 million in 2022 and is projected to reach USD 1508.58 million by 2028, exhibiting a CAGR of 4.54% during the forecast period.
The Global Equine Pharmaceuticals and Supplements Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Equine Pharmaceuticals and Supplements utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Top Key Players Mentioned Are: Boehringer Ingelheim, Merck Animal Health, Zoetis, Bayer Animal Health, Elanco Animal Health, Dechra Veterinary Products, CEVA, Virbac, Norbrook Equine, Kyoritsu Seiyaku, Vetoquinol, Protexin Healthcare, Audevard, Ouro Fino Saude
Global Equine Pharmaceuticals and Supplements Market Segmentation
By Type, Equine Pharmaceuticals and Supplements market has been segmented into:Pharmaceuticals
Supplements
By Application, Equine Pharmaceuticals and Supplements market has been segmented into:
Thoroughbred Horse
Other Types of Horses
Regional Analysis:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Equine Pharmaceuticals and Supplements market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Equine Pharmaceuticals and Supplements market.
Top Key Players Covered in Equine Pharmaceuticals and Supplements market are:
Boehringer Ingelheim
Merck Animal Health
Zoetis
Bayer Animal Health
Elanco Animal Health
Dechra Veterinary Products
CEVA
Virbac
Norbrook Equine
Kyoritsu Seiyaku
Vetoquinol
Protexin Healthcare
Audevard
Ouro Fino Saude
Objective to buy this Report:
1. Equine Pharmaceuticals and Supplements analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Equine Pharmaceuticals and Supplements market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Equine Pharmaceuticals and Supplements Market by Type
5.1 Equine Pharmaceuticals and Supplements Market Overview Snapshot and Growth Engine
5.2 Equine Pharmaceuticals and Supplements Market Overview
5.3 Pharmaceuticals
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Pharmaceuticals: Geographic Segmentation
5.4 Supplements
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Supplements: Geographic Segmentation
Chapter 6: Equine Pharmaceuticals and Supplements Market by Application
6.1 Equine Pharmaceuticals and Supplements Market Overview Snapshot and Growth Engine
6.2 Equine Pharmaceuticals and Supplements Market Overview
6.3 Thoroughbred Horse
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Thoroughbred Horse: Geographic Segmentation
6.4 Other Types of Horses
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Other Types of Horses: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Equine Pharmaceuticals and Supplements Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Equine Pharmaceuticals and Supplements Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Equine Pharmaceuticals and Supplements Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 BOEHRINGER INGELHEIM
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 MERCK ANIMAL HEALTH
7.4 ZOETIS
7.5 BAYER ANIMAL HEALTH
7.6 ELANCO ANIMAL HEALTH
7.7 DECHRA VETERINARY PRODUCTS
7.8 CEVA
7.9 VIRBAC
7.10 NORBROOK EQUINE
7.11 KYORITSU SEIYAKU
7.12 VETOQUINOL
7.13 PROTEXIN HEALTHCARE
7.14 AUDEVARD
7.15 OURO FINO SAUDE
Chapter 8: Global Equine Pharmaceuticals and Supplements Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Pharmaceuticals
8.2.2 Supplements
8.3 Historic and Forecasted Market Size By Application
8.3.1 Thoroughbred Horse
8.3.2 Other Types of Horses
Chapter 9: North America Equine Pharmaceuticals and Supplements Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Pharmaceuticals
9.4.2 Supplements
9.5 Historic and Forecasted Market Size By Application
9.5.1 Thoroughbred Horse
9.5.2 Other Types of Horses
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Equine Pharmaceuticals and Supplements Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Pharmaceuticals
10.4.2 Supplements
10.5 Historic and Forecasted Market Size By Application
10.5.1 Thoroughbred Horse
10.5.2 Other Types of Horses
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Equine Pharmaceuticals and Supplements Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Pharmaceuticals
11.4.2 Supplements
11.5 Historic and Forecasted Market Size By Application
11.5.1 Thoroughbred Horse
11.5.2 Other Types of Horses
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Equine Pharmaceuticals and Supplements Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Pharmaceuticals
12.4.2 Supplements
12.5 Historic and Forecasted Market Size By Application
12.5.1 Thoroughbred Horse
12.5.2 Other Types of Horses
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Equine Pharmaceuticals and Supplements Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Pharmaceuticals
13.4.2 Supplements
13.5 Historic and Forecasted Market Size By Application
13.5.1 Thoroughbred Horse
13.5.2 Other Types of Horses
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Equine Pharmaceuticals and Supplements Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Pharmaceuticals
14.4.2 Supplements
14.5 Historic and Forecasted Market Size By Application
14.5.1 Thoroughbred Horse
14.5.2 Other Types of Horses
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Equine Pharmaceuticals and Supplements Scope:
|
Report Data
|
Equine Pharmaceuticals and Supplements Market
|
|
Equine Pharmaceuticals and Supplements Market Size in 2025
|
USD XX million
|
|
Equine Pharmaceuticals and Supplements CAGR 2025 - 2032
|
XX%
|
|
Equine Pharmaceuticals and Supplements Base Year
|
2024
|
|
Equine Pharmaceuticals and Supplements Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Boehringer Ingelheim, Merck Animal Health, Zoetis, Bayer Animal Health, Elanco Animal Health, Dechra Veterinary Products, CEVA, Virbac, Norbrook Equine, Kyoritsu Seiyaku, Vetoquinol, Protexin Healthcare, Audevard, Ouro Fino Saude.
|
|
Key Segments
|
By Type
Pharmaceuticals
Supplements
By Applications
Thoroughbred Horse
Other Types of Horses
|
